T cell

Handshake jigsaw puzzle
#Autoimmune disease #Genomics #T cell

Genomics and Greywolf partner on autoimmune disease treatments 

Techbio company Genomics has partnered with biotech company Greywolf Therapeutics to advance novel antigen modulation treatments to treat autoimmune diseases.  Under the agreement, Genomics is set to curate and analyse large-scale genetic datasets to assess how variants of the ERAP (Endoplasmic Reticulum Aminopeptidases) enzymes influence disease risk across… Read More

#Business & Investment #News

#Cancer research #Oncology #T cell #Tumour biology #Tumour microenvironment (TME)

The missing link in treating cancer

Eden Ben, CEO of Amorphical, and Dr Yigal Blum, CTO of Amorphical, argue that targeting the hostile tumour microenvironment is the key to effectively treating this aggressive cancer.  For years, the conversation around pancreatic cancer has focused on the tumour itself, the “broken” cells that won’t stop… Read More

#Exclusive Content

#ABPI #Clinical trials #GLP-1 #Immune response #NHS #Obesity #Oncology #Prostate cancer #T cell #Texas A&M University Health Science Center #Weight loss

DDW Highlights: 31 March 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates the key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a study found obesity could be treated in other ways than through drugs… Read More

#Podcasts

#ABPI #Clinical trials #Dementia #GLP-1 #Immune response #Neuroscience #NHS #Obesity #Oncology #Prostate cancer #T cell #Texas A&M University Health Science Center #Tregs #Weight loss

This week in Drug Discovery (23 – 27 March) 

News round-up for 23 – 27 March by Bruno Quinney, Content Team at DDW.  This week, obesity could be treated in other ways than through drugs suppressing appetite. Elsewhere, prostate cancer has been a central theme in cancer research.   The top stories:    Obesity… Read More

#News

Prostate cancer cells
#Immune response #Prostate cancer #T cell

‘Supercharged’ T cells could improve prostate cancer treatment 

Scientists have engineered new ‘supercharged’ immune cells that could attack prostate cancer more effectively.  Researchers at UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, have engineered a new class of ‘supercharged’ T cells that are stronger, longer lasting, and… Read More

#Cancer Research #News

T cells
#Genetics #Sonoma Biotherapeutics #T cell

SonomaBio receives $300,000 grant to develop T-cell therapies 

Biotechnology company Sonoma Biotherapeutics has received a $300,000 G-Rex Grant to expedite the production of gene-modified regulatory T-cell therapies.  The grant was awarded by gene therapy manufacturer ScaleReady, aiming to advance the state of cell and gene-modified cell therapy development.   SonomaBio will now expedite the development of a G-Rex-based manufacturing process… Read More

#Business & Investment #News

#Autoimmune disease #Clinical research #Sjögren’s disease #T cell

Researchers find existing drug could treat Sjögren’s disease

Researchers are closer to understanding what drives the autoimmune disorder Sjögren’s disease, thanks to new discoveries about the role of calcium signalling, regulatory T cells, and interferon. The study, led by scientists at NYU College of Dentistry and NYU Grossman School of Medicine, was published in Science Translational Medicine. Read More

#News